Teva bets on new therapeutic uses of known molecules

[riky]

Teva bets on new therapeutic uses of known molecules

<p><a href="http://news.yahoo.com/teva-bets-therapeutic-uses-known-molecules-150444695--finance.html"><img src="http://l3.yimg.com/bt/api/res/1.2/zrBmML4AJxLfl.uoPn_SGg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9NzU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-12-08T150444Z_1_CBRE9B715W200_RTROPTP_2_TEVA.JPG" width="130" height="86" alt="A sign bearing the logo of Teva is seen in Jerusalem" align="left" title="A sign bearing the logo of Teva is seen in Jerusalem" border="0" /></a>By Tova Cohen TEL AVIV (Reuters) - Teva Pharmaceutical Industries, the world's biggest maker of generic drugs, estimates its pipeline of so-called new therapeutic entities (NTEs) could generate revenue of $1 billion to $1.5 billion by 2018. This figure could jump to $3 billion in 2020, Elisabeth Kogan, Teva's senior vice president of generic research and development, told reporters on Sunday. The NTE program, launched a year ago, is a major element in Teva's strategy for growth and the company has 15 such products in its pipeline. One such product, called Adasuve, which it licensed from Alexza Pharmaceuticals, has been approved and is expected to be launched in the United States in about a month, Teva officials said.</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login